GTC Biotherapeutics

Manufacturing · Massachusetts, United States · 51-200 Employees

View Company Info for Free

Overview

Headquarters

175 Crossing Blvd Ste 410, Framingham, M...

Phone Number

(508) 620-9700

Revenue

$18.4 Million

Industry

Manufacturing Pharmaceuticals Business Services Research & Development
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1

About GTC Biotherapeutics

GTC Biotherapeutics develops, supplies, and commercializes therapeutic proteins produced through transgenic animal technology. In addition to ATryn®, GTC is developing a portfolio of recombinant human plasma proteins with known therapeutic properties. These proteins include recombinant forms of human coagulation factors VIIa and IX, which are used for the treatment of hemophilia, and alpha-1 antitrypsin. GTC also has a monoclonal antibody portfolio that includes a monoclonal antibody to CD20 and a monoclonal antibody to CD137. GTC's intellectual property includes a patent in the United States through 2021 for the production of any therapeutic protein in the milk of any transgenic mammal. GTC's transgenic production platform is particularly well suited to enabling cost effective development of proteins that are difficult to express in traditional recombinant production systems as well as proteins that are required in large volumes .Explore more
GTC Biotherapeutics's Social MediaPopular SearchesGtc Biotherapeutics IncGtc BiotherapeuticsBiotherapeutics IncSIC Code 28,283NAICS Code 32,325Show more

GTC Biotherapeutics Org Chart

PhoneEmail
NH
United States flag for contact location.

Chief Information Officer

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.
AH
United States flag for contact location.

Help Desk Analyst

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is GTC Biotherapeutics your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Illustration of an envelope

Company Profile Activity

i

Among all Manufacturing companies

Low Activity

High Activity

Activity Insights

GTC Biotherapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.

What does this means?

GTC Biotherapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about GTC Biotherapeutics.

GTC Biotherapeutics Tech Stack

A closer look at the technologies used by GTC Biotherapeutics

Top Manufacturing Companies

Frequently Asked Questions Regarding GTC Biotherapeutics

What is GTC Biotherapeutics's official website?
GTC Biotherapeutics's official website is www.gtc-bio.com
What is GTC Biotherapeutics's Revenue?
GTC Biotherapeutics's revenue is $18.4 Million
What is GTC Biotherapeutics's SIC code?
GTC Biotherapeutics's SIC: 28,283
What is GTC Biotherapeutics's NAICS code?
GTC Biotherapeutics's NAICS: 32,325
How many employees does GTC Biotherapeutics have?
GTC Biotherapeutics has 51-200 employees
What industry does GTC Biotherapeutics belong to?
GTC Biotherapeutics is in the industry of: Manufacturing, Pharmaceuticals, Business Services
What companies has GTC Biotherapeutics acquired?
GTC Biotherapeutics has acquired the companies: Lfb - Hemoderivados E Biotecnologia, Caf Dcf, KMS Plasmaservice
What technology does GTC Biotherapeutics use?
Some of the popular technologies that GTC Biotherapeutics uses are: Cloudflare Website Optimization, Cloudflare CDN, jQuery, Modernizr
How do I contact GTC Biotherapeutics?
GTC Biotherapeutics contact info: Phone number: (508) 620-9700 Website: www.gtc-bio.com
What does GTC Biotherapeutics do?

GTC Biotherapeutics develops, supplies, and commercializes therapeutic proteins produced through transgenic animal technology. In addition to ATryn®, GTC is developing a portfolio of recombinant human plasma proteins with known therapeutic properties. These proteins include recombinant forms of human coagulation factors VIIa and IX, which are used... for the treatment of hemophilia, and alpha-1 antitrypsin. GTC also has a monoclonal antibody portfolio that includes a monoclonal antibody to CD20 and a monoclonal antibody to CD137. GTC's intellectual property includes a patent in the United States through 2021 for the production of any therapeutic protein in the milk of any transgenic mammal. GTC's transgenic production platform is particularly well suited to enabling cost effective development of proteins that are difficult to express in traditional recombinant production systems as well as proteins that are required in large volumes .Read More

What are GTC Biotherapeutics social media links?
GTC Biotherapeutics Linkedin page
Is GTC Biotherapeutics a public company?
GTC Biotherapeutics is private company therefore does not currently have an official ticker symbol
See more information about GTC Biotherapeutics

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.